Nippon Sanso Holdings Corporation earnings date
Want to see JP:4091 full AI Analyst Report?
Nippon Sanso Holdings Corporation (4091) Q3 2025 Earnings Report
JP:4091 Q3 2025 EPS Results
- Actual EPS
- JPY 82.51
- Consensus EPS
- JPY 78.71
- Beat/Miss
- Beat by +JPY 3.80
- One Year Ago EPS
- JPY 65.34
JP:4091 Q3 2025 Revenue Results
- Actual Revenue
- JPY 346.89B
- Expected Revenue
- JPY 344.97B
- Beat/Miss
- Beat by +JPY 1.92B
- YoY Revenue Growth
- +5.69%
Earnings Announcement Details
- Quarter
- Q3 2025
- Date
- 02/04/2026
- Time
- TBA
- Conference Call
- Wednesday, February 4, 2026
Nippon Sanso Holdings Corporation's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
Q3 2025 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2025 Earnings Call Summary
The call presented solid operational and financial progress: mid-single digit revenue growth, stronger core operating income and margin expansion, significant operating cash flow improvement, strategic M&A to expand regional footprints, and successful refinancing that reduces interest costs. Offsets include volume softness in parts of the business, regionally mixed profitability (Asia & Oceania pressures), a substantial increase in investing outflows and a meaningful free cash flow decline, plus project execution and leverage implications from acquisitions and suspended projects. On balance the positive execution on pricing, productivity, margin expansion, backlog size, and strategic deals outweigh the near-term cash/volume challenges.
The company kept full-year sales guidance unchanged at ¥1.3 trillion while raising core operating income (COI) by ¥8.0 billion (up 4.5%) to ¥185.0 billion and nudging operating income up ¥1.0 billion to ¥178.0 billion; pre-tax income is projected at ¥156.5 billion and net income at ¥110.0 billion (¥107.0 billion attributable to the parent). Q3 trends that underpin the guidance included revenue +3.8% (ex-currency ~+1.2%), COI +7.5% (ex-currency +4.5%), COI margin +50 bps to 14.1% and EBITDA margin +50 bps to 23%; the Q3 consolidated variance breakdown was currency +2.6%, price +2.0%, volume -1.4%, pass-through +0.4% and other +0.2%. Management assumes USD/JPY ¥152.45 and EUR/JPY ¥165.83 for Q4, and notes currency sensitivity of ~¥2.4 billion revenue / ¥350 million COI per ¥1 vs USD and ~¥1.9 billion revenue / ¥350 million COI per ¥1 vs EUR. Key cash and investment metrics cited were backlog ≈¥170 billion (projects ≥¥500 million), operating cash flow up ~19% year-to-date (~¥24 billion), free cash flow down ~31% YTD due to higher CapEx and M&A, and refinancing of ¥75 billion hybrid debt in Q3 (¥175 billion refinanced in ~1 year) saving roughly 90 basis points in annual effective interest expense.
- Consolidated Revenue GrowthQ3 revenue increased 3.8% year-over-year (Oct–Dec 2024). Excluding favorable currency, revenue rose ~1.2%. Management maintained full-year sales guidance at ¥1.3 trillion.
- Core Operating Income and Margin ImprovementCore operating income (COI) increased 7.5% year-over-year (ex-currency +4.5%). COI margin expanded by 50 basis points to 14.1%. EBITDA margin also improved by 50 basis points to 23%.
- Strong Operating Cash Flow and Financial ActionsOperating cash flow improved ~19% year-to-date (about ¥24 billion). The company refinanced ¥75 billion of hybrid debt in Q3 (¥175 billion refinanced in just over one year), saving nearly 90 basis points in effective interest expense per annum.
- Upward Revision to COI GuidanceCore operating income guidance was revised up by ¥8 billion (4.5%) to ¥185 billion; operating income guidance increased by ¥1 billion to ¥178 billion. Net income forecast for the year is ¥110 billion (¥107 billion attributable to parent).
- Backlog and Growth-related ProjectsBacklog of projects (≥¥500 million) as of Dec 31, 2024 is approximately ¥170 billion, with environment/hydrogen‑related projects accounting for roughly 45% of the backlog, indicating sizable future CapEx-driven growth opportunities.
- Strategic Acquisitions to Expand Geographic and Service FootprintAnnounced acquisitions: Coregas Group (Australia/New Zealand) and Esteve Teijin Healthcare (Spain). Coregas expected to increase the company’s presence in Australia by ~50% (raising Australia’s share of Asia & Oceania sales from ~30% to ~40%). The Spain homecare acquisition expands European medical/homecare footprint (asset <3% of group revenue). Both deals targeted to close mid‑2025 pending approvals.
- Segment Standouts — Europe and U.S.Europe: revenue ¥83.3 billion, +10.0% YoY (ex-FX +6.9%); segment income ¥15.4 billion, +16.4% YoY (ex-FX +13.2%). U.S.: revenue ¥90.5 billion, +3.3% YoY (but ex-FX -2.1%); segment income ¥13.5 billion, +9.3% YoY (ex-FX +3.4%).
- Thermos Business ResilienceThermos revenue ¥8.0 billion, +3.3% YoY; segment profit ¥1.6 billion, +11.8% YoY (design/product updates helped offset yen-driven cost increases).
JP:4091 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 04, 2027 | 2026 (Q3) | 73.62- | 82.51 | ― | ― |
| Nov 03, 2026 | 2026 (Q2) | 79.6682.88 | 67.07 | 23.57% (+15.81) | |
| Jul 29, 2026 | 2026 (Q1) | 82.01101.00 | 65.6 | 53.96% (+35.40) | |
| May 11, 2026 | 2025 (Q4) | 76.5571.04 | 49.21 | 44.36% (+21.83) | |
| Feb 04, 2026 | 2025 (Q3) | 78.7182.51 | 65.34 | 26.28% (+17.17) | |
| Oct 30, 2025 | 2025 (Q2) | 70.2467.07 | 46.46 | 44.36% (+20.61) | |
| Jul 31, 2025 | 2025 (Q1) | 70.2365.60 | 67.19 | -2.37% (-1.59) | |
| May 12, 2025 | 2024 (Q4) | 61.2249.21 | 75.1 | -34.47% (-25.89) | |
| Feb 05, 2025 | 2024 (Q3) | 68.1665.34 | 57.4 | 13.83% (+7.94) | |
| Oct 31, 2024 | 2024 (Q2) | 69.1146.46 | 55.42 | -16.17% (-8.96) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

